Literature Review 7 pages

Running head: BEST PRACTICES IN PREVENTING RECURRENT MYOCARDIAL INFARCTIONS 2

3

Running Head: PREVENTING RECURRENT MYOCARDIAL INFARCTIONS

Best Practices in Preventing Recurrent Myocardial Infarctions (Revised)

Patience Nehikhare

Houston Baptist University

NURS 5301: Advanced Nursing Research

Dr. Melanie Eld

August 6, 2020

Best Practices in Preventing Recurrent Myocardial Infarctions

It is well established amongst most medical professionals that a myocardial infarction, or heart attack, is a dangerous medical emergency. In layman terms, a myocardial infarction occurs when blood flow is blocked in one of the vessels that supply the heart. There is a range of effective treatment options once the patient is stabilized. Long-term prevention of myocardial infarction is the goal and is usually achieved with appropriate lifestyle changes and other behavior modifications. However, once a person has suffered from a myocardial infarction, an additional heart attack's risk significantly increases. Most research has focused on primary prevention of this challenging disorder, but less research has been conducted regarding methods and best practices to prevent a recurrent myocardial infarction. This paper will report a literature review of appropriate interventions that can reduce the risk of experiencing a second myocardial infarction.

Literature review

Brovyk, Rindina, Kravchun, Tabachenko, Yermak, Romanyuk (2019) Factors associated with recurrent cardiovascular problems in obese patients previously had a heart attack

Brovyk, Rindina, Kravchun, Tabachenko, Yermak, and Romanyuk (2019) investigated how obesity significantly contributed to repetitive cardiovascular events. Seventy-five patients To analyze the incidence of frequent cardiovascular events in obese patients after MI during a 6-month duration follow-up, depending on the combination of ticagrelor or Plavix with aspirin as part of dual antiplatelet therapy (Kern, 2012). The research was in conduction in 75 patients with AMI, ST-segment elevation, and concomitant obesity was divided into two subgroups. The first included 31 patients who received the combination of ASA + ticaglelor. The second 44 diseased treated with the conjunction of ASA + clopidogrel in a DAPT; GRACE scale for risk of hospitalization and 6-month mortality.

In the six-month duration follow up, 28 patients had recurrent MI together with unstable angina (UA), 37.56 % of all patients. In 37.56 % of diseased with acute MI with an elevation of the ST section and adjunctive obesity, there was a recurrent coronary event in the form of unstable angina or MI in the existence of an excellent GRACE score. Treatment recommendations for obese patients who have suffered an MI should include Asprin and ticagrelor to prevent recurrent events. Obese patients should be more thoroughly assessed to determine their risk factors for MI, and appropriate interventions should immediately begin.

Myftiu, Sulo, Burazeri, Daka, Sharka, Shkoza, Sulo (2017) Risk factors in initial and recurrent MI

To analyze the possible un-similarities in the in-hospital and medical profile treatment amongst in-patients with such incidents and an AMI that is recurrent. The test was in conduction in 324 diseased in 'Mother Teresa health facility in Albania's coronary section from the year 2013 to the year 2014. Logistical fixation analysis was in place to measure un-similarities in the earlier, together with recurrent AMI (Hemmings & Egan, 2013). Fifty represented 15.4 percent and had anterior AMI, repeated incidences were aged where (p=0.01), mostly women were (p=0.01), minimal literacy levels were (p=0.01), together with fewer smokers where (p=0.03), repeated incidences at most cases experience heart failure where OR is equal to (2.48 or 95%). CL represents (1.31-4.70), afflicted left part ventricular expulsion fraction is as OR equals to (1.97 that is 95%), CL is (1.05-3.71) together with double vessel infections is OR equals to (6.32 that is 95%) CL is (1.43-28.03) in comparison with incident scenarios.

Most severe medical expressions in the condition and minimum utilization of treatment in repeated AMI causes poor prognosis. There is an immediate necessity in focusing on preventive strategies. Patients with associated risk factors need more in-depth treatment planning to encourage significant lifestyle changes.

Karjalainen, Nimela, Laine, Airaksinen, Ylitalo, Nammas (2016). Stent under expansion after stent implementation following an MI

The study performed an analysis of comparing post-coronary dilation in chronic MI prevention to those that did not have post-coronary dilation. It was a post hoc analysis in basal ACS attempts, which involved 827 diseased (1:1) who had ACS to get everolimus-eluting tubing or titanium-nitride-oxide coated bioactive tubing's. Out of the 827 infected who took part in the basal ACS attempts, 357 that is 43.2%, goes through PD. They would undergo an average follow up for five years. Diseased individuals who experienced the PD had lower non-fatal MI scenarios at prolonged follow-ups when, in comparison with the patients who did not go through it (4.5% versus 8.5%, p represents (0.02).

The MACE rates of 15.7% versus 15.1%, where p represents (0.81), diseased individuals who received treatment with initial transdermic coronary intercession for ACS who were through the PD had minimal frequent. Non-fatal MI scenarios for a prolonged follow up when in comparison with the patients who never underwent through it; rates of MACE were different in a significant manner. More studies should observe the effects of PD stents to prevent recurrent MI. Patients with a stent should be assessed to determine whether post-coronary dilation occurred.

Kanuri, Ipe, Kassab, Gao, Liu, Skaar, Kreutz (2018). Modification of the physiologic functioning in the cardiovascular system due to variations in micro-RNA

The research was performing a study on circulatory miRNAs possible events as the reliable biomarkers in the stratification of risks and earlier identification of cardiovascular scenarios. Blood representations were collected from four hundred and thirty-seven patients who had a cardiac operation, who then had experiences of repeated cardiovascular situations in an average follow up of one and a half years (Watchie, 2020). A differential form of mi-RNA aspect was found in controls, CAD diseased with no events, together with CAD diseased with repeated occurrences. Mi-RNA was earlier in association with stroke, arrhythmia, heart hypertrophy, cardiac failure, angiogenesis, platelets, vascular delicate muscular cells, endothelial responsibilities, CAD, and MI happens to be in expression in the case study.

70 mi-RNA, which represents FDR less than 0.05, were in connection with repeated MI and future tubing thrombosis as in comparison with CAD diseased with sub-sequential non-event follow-ups (Hutchison, 2019). Mi-RNA following generation running gives a demonstration of altered finger profiles of blood mi-RNA aspect in people who had following repeated thrombotic scenarios on a measure of clinical therapy when in comparison with patients who had no repeated cardiovascular situations. Investigating the specific risk factors in Mi-RNA sequences may be useful. Knowing a patient is at higher risk due to Mi-RNA variations could assist with treatment planning.

Osmak, Titov, Matveeva, Bashinskaya, Shakhnovich, Sukhinina, Kukava, Ruda, Favorova (2018). Adverse cardiovascular events and increased mortality following an MI

It was a retrospective study whose aim was to evaluate the allelic fluctuations in 9p, where it represents 21.3 venue and twenty-one atherogenesis genes concerning the development of rough heart events in a study of diseased of Russian race after the initial AMI during a prolonged follow-up. The study involved 133 diseased, who were 104 males together with 29 females. The average age was 53.9 ± years 9.3, with the initial MI being the indicator scenario of enrollments in the year 2013 to the study on the grounds of prolonged follow-up. Link analysis concerning the polymorphous loci and Haplo's perspective of 4.2 packages gave the entire link imbalance of 10757278rs and 133049rs in the 9ptwenty one area D equals one and LOD is less than 2.

Kaplan-Meier arc often depicts of un-favorable results in various times for carriers in genotypes or alleles of 9ptwenty one (133049rs, 10757278rs) together with MTHFR, which represents 1801133rs. Some atherogenesis and myocardial Infarction loci can influence prolonged infringement prognosis of rough heart events in diseased that go through initial MI generally 9ptwenty one 133049rs*GG, and MTHFR 1801133rs*TT happen to be hazard genotypes in un-favorable results. Persons with Russian ethnicity could benefit from a genetic analysis before an MI.

Radovanovic, Maurer, Bertel, Witassek, Urban, Stauffer, Pedrazzini, Erne (2016). Therapy and outcome differences in patients with initial and recurrent MI

The study aims to evaluate the prior MI impact on outcomes and therapies in the diseased person who is given an evaluation MI on the ST. All patients having the STEMI found from 2002 to 2014 in the AMIS registry plus were in inclusion(Mehta, 2012). Consequences were analyzed by the use of regression of the logistic multivariate. From 19, 665 STEMI diseased persons, 2845, that is 14%, were having re-MI. These infected individuals were aged 69.5 years and 64.2 years, most frequently were men, having more risk factors, and more comorbidity (Fuster & Narula, 2012). Diseased individuals are having re-MI presented in 25 minutes earlier than the one having first MI were most frequent in the class of Killip of ¾. And were less likely to be receiving a guide with the recommendation of drug therapy, aspirin P2Y12 inhibitors 76% versus 83%; p is less than 0.001, 93% versus 97%; p is less than 0.001, or statins 73% versus 77%; p is less than 0.001, or undergo significant intervention of transdermic coronary of 77% versus 87%; p is less than 0.001.

A sub-group name n equals 4486 was complied after a one year discharge and was 3893 with the MI at first, together with 593 with re-MI having initialized hospitalization. Rate of crude was 2.9 percent to the diseased person having the 1st MI as 6.7 percent for the ones with re-MI and 1.68, 95 percent CI 1.14–2.47; p represents 0.008. The infected persons having the recurrent M1 were less receiving the evidence care or had wrong health centers in one-year consequences than a diseased person having first MI. Patients with recurrent MI find help for their way of discomfort even if they don't have symptoms according to levels of biomarker; they also had a small recurrent MI. Long term and short term patients management with recurring MI must have an improvement.

Dias, Maier, Junior, Moser, Santos, Oliveira (2019). Possible factors associated with risk for recurrent MI

The aim was investigating the factors possible for the occurrence of acute myocardial infarction of the diseased person going in the care of coronary in the relatives’ perspective. Qualitative, descriptive, and case studies were in use in collecting data using pilot interviews. The relative had a report that the physically intense activity done by the diseased person, taking off more alcohol and other drugs therapy, have also contributed to another event of the AMI (Basson & Lerman, 2019). The similar said that the received guidance, they were for the prescribed medicines; highlight the lack of advice concerning the changes in the realization of the similar professional of health care and lifestyle, particularly the nursing staff. The guidelines in accordance to the increase have not to effect in prevention the AMI recurrence and highlight the requirements of re-thinking on the role of the professional nursing having the relationship to the provided guidelines, as a kind of facilitation to the diseased person to the changes of life and medication treatment.

Implementing of the permanent and a particular program of education for these caring lines are required in the highlighting of the nursing actions of producing measures of rehabilitation and cardiovascular prevention, ensure that the social, mental and physical condition and focus on the disease (Crawford, DiMarco & Paulus, 2019). Healthcare facilities need specific treatment plans established for patients with a previous MI. Risks for recurrent MI in the year following the initial. Do re-hospitalizations after AMI further increase the risk of recurrent AMI? The Clinical Classifications Software was used to classify re-hospitalizations into disease categories. A Cox regression model was fit accounting for CCS-specific hospitalizations as time-varying variables and patient characteristics at discharge for the index AMI, adjusting for the competing risk of death. The rate of 1-year recurrent AMI was 5.3%. 95% CI, 5.27%–5.41%, and median or inter-quartile range time from discharge to recurrent AMI was 115 in 34 to 230 days.

Eleven disease categories; diabetes mellitus, anemia, hypertension, coronary atherosclerosis, heart disease, pneumonia, chest pain, gastrointestinal and chronic obstructive pulmonary disease, bleeding, and renal failure, complications of implant or graft were associated with increased risk of recurrent AMI. Septicemia was associated with lower recurrence risk. Hazard ratios ranged from 1.6, 95 percent CI, 1.55 to 1.70, heart disease to 1.1, 95 percent CI, 1.04 to 1.25, pneumonia to 0.6, 95% CI, 0.58–0.71, septicemia. Patient risk of recurrent AMI changed based on the occurrence of hospitalizations after the index AMI. Risk-stratification after an acute myocardial infarction is necessary to inform the choice of clinical strategies. Improving post-acute care to prevent unplanned re-hospitalizations, especially re-hospitalizations for chronic diseases, and extending the focus of outcomes measures to condition-specific re-hospitalizations within 30 days and beyond is vital for the secondary prevention of AMI.

Conclusion

A sharp MI is in management by the team of international professionals with a dedication to heart failure. However, the cardiologist, the team, has a cardiac surgeon, a cardiologist's intervention, rehabilitation of cardiac, vital cardiology, and care nurses, together with physical therapists. Since most of the patients die before going to health centers, the key is educating the diseased person of the early arrival and symptoms to the emergency department. The primary care, nurse practitioner, and pharmacist must inform the patient on taking nitro-glycerine, and if not relieved after three doses, call 911. The nurses must communicate immediately with the team of the inter-professional as the reperfusion time is limited. The cardiologist must be in consideration of the vessel clot independence to the indication and symptoms duration. All diseased individuals need monitoring of the ICU.

Nurses must be vigilant on the concern towards the potentiality of life threaten, communicate, and complications with the team if they are not healthy. None of the patients should be discharged prematurely since MI complications may occur even for a week after MI. After the stabilization, diseased individuals need to be educated by the nurses concerning the risk reduction factor for coronary artery disease. After a patient is discharged, the sick person must come into a cardiac rehabilitating unit, consume a healthier diet, end smoking, reduce alcohol, reduction in body weight, together with lowering the bodily fluid level of dextrose and cholesterol. Diseased person must get education comprising of medication benefits and to lower blood cholesterol. It is crucial to check for the interaction and educate the patient concerning the compliance important

References

Bohn, B., Schöfl, C., Zimmer, V., Hummel, M., Heise, N., Siegel, E., Karges, W., Riedl, M., &

Holl, R. W. (2016). Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis. Cardiovascular Diabetology, 15, 1–17. https://doi.org/10.1186/s12933-016-0391-8

Borovyk K., Rindina N., Kravchun P., Tabachenko O., Yermak O., & Romanyuk M. (2019). The Effects of Dual Antiplatelet Therapy on the Occurrence of Recurrent Cardiovascular Events After Myocardial Infarction in Obese Patients. Львівський Клінічний Вісник, 1(25), 34–38. https://doi.org/10.25040/lkv2019.01.034

Kanuri, S. H., Ipe, J., Kassab, K., Gao, H., Liu, Y., Skaar, T. C., & Kreutz, R. P. (2018). Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction. Atherosclerosis, 278, 232–239. https://doi.org/10.1016/j.atherosclerosis.2018.09.021

Karjalainen, P. P., Niemelä, M., Laine, M., Airaksinen, J. K. E., Ylitalo, A., & Nammas, W. (2017). Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial). The American Journal of Cardiology, 119(3), 345–350. https://doi.org/10.1016/j.amjcard.2016.09.057

Korenevskiy, N. A., Seregin, S. P., Ivanov, V. A., Kolesnik, A. I., Siplivy, G. V., Makkonen, K. F., Dmitrieva, V. V., Kicha, D. I., & Zubarev, D. A. (2018). Prognosis of Recurrent Myocardial Infarction Based on Shortliffe Fuzzy Models Using the Electrical Characteristics of Biologically Active Points. Biomedical Engineering, 1, 68. https://doi.org/10.1007/s10527-018-9784-1

Myftiu Sokol, Sulo Enxhela, Burazeri Genc, Daka Bledar, Sharka Ilir, Shkoza Artan, & Sulo Gerhard. (2017). Clinical profile and management of patients with incident and recurrent acute myocardial infarction in Albania - a call for more focus on prevention strategies. Slovenian Journal of Public Health, 56(4), 236–243. https://doi.org/10.1515/sjph-2017-0032

Osmak, G. J., Titov, B. V., Matveeva, N. A., Bashinskaya, V. V., Shakhnovich, R. M., Sukhinina, T. S., ... & Favorova, O. O. (2018). Impact of 9p21. 3 region and atherosclerosis-related genes' variants on long-term recurrent hard cardiac events after a myocardial infarction. Gene, 647, 283-288.

Radovanovic, D., Maurer, L., Bertel, O., Witassek, F., Urban, P., Stauffer, J.-C., Pedrazzini, G.,

& Erne, P. (2016). Treatment and outcomes of patients with recurrent myocardial infarction: A prospective observational cohort study. Journal of Cardiology, 68(6), 498–503. https://doi.org/10.1016/j.jjcc.2015.11.013

Taynara Maria dos Santos Dias, Suellen Rodrigues de Oliveira Maier, Joaquim Rosa Soares

Junior, Gelson Aguiar da Silva Moser, Bruno da Silva Santos, & Wanmar de Souza Oliveira. (2019). Recurrent myocardial infarction from the perspective of the victim’s family member: case report. ABCS Health Sciences, 44(3).

https://doi.org/10.7322/abcshs.v44i3.1205

Yun Wang, Leifheit, E., Normand, S.-L. T., Krumholz, H. M., & Wang, Y. (2020). Association

Between Subsequent Hospitalizations and Recurrent Acute Myocardial Infarction Within 1 Year After Acute Myocardial Infarction. Journal of the American Heart Association, 9(6), 1–13. https://doi.org/10.1161/JAHA.119.014907